IL2 and acute myeloid leukemia: Some studies have reported that interleukin (IL)-2 expansion could recruit and activate key regulators involved in lytic immunological synapse formation of CB-derived NK cells, enabling effective cytotoxicity against killing of acute myeloid leukemia (AML) cells in vitro and in vivo [21, 22].